Carisoprodol Tablets got FDA Approval on 10/20/2021

CARISOPRODOL TABLETS, USP, 350 MG - carisoprodol tablet

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CARISOPRODOL TABLETS safely and effectively. See full prescribing information for CARISOPRODOL TABLETS.

Carisoprodol Tablets, USP are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.

Carisoprodol Tablets, USP should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [ see Dosage and Administration (2)].